Malvern Panalytical has acquired Dimer Instruments. The financial terms of the transaction were not disclosed.
The acquisition aims to accelerate innovation in biopharmaceutical analysis. Malvern Panalytical had previously made a minority investment in Dimer Instruments on April 25, 2024, and had worked closely with the company since then. The acquisition builds on this collaboration, bringing the two organizations together to advance the development of new solutions for biopharmaceutical customers.
Christian Sauber, President of Malvern Panalytical, stated that the collaboration with Dimer Instruments had already delivered the Zetasizer Core product. He added that bringing the teams together will allow them to build on that success, develop new technologies, and help biopharmaceutical scientists address critical workflow challenges.